1. Home
  2. DSWL vs VERU Comparison

DSWL vs VERU Comparison

Compare DSWL & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Deswell Industries Inc.

DSWL

Deswell Industries Inc.

N/A

Current Price

$2.88

Market Cap

48.4M

Sector

Industrials

ML Signal

N/A

Logo Veru Inc.

VERU

Veru Inc.

N/A

Current Price

$2.12

Market Cap

41.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSWL
VERU
Founded
1987
1971
Country
Macau
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.4M
41.9M
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
DSWL
VERU
Price
$2.88
$2.12
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $25.67
AVG Volume (30 Days)
5.5K
★ 211.4K
Earning Date
11-16-2026
12-16-2026
Dividend Yield
★ 7.02%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $16,296,958.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.59
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.80
$2.05
52 Week High
$4.06
$7.33

Technical Indicators

Market Signals
Indicator
DSWL
VERU
Relative Strength Index (RSI) 32.51 40.22
Support Level N/A $2.11
Resistance Level $3.48 $2.68
Average True Range (ATR) 0.06 0.13
MACD -0.02 -0.01
Stochastic Oscillator 5.02 25.75

Price Performance

Historical Comparison
DSWL
VERU

About DSWL Deswell Industries Inc.

Deswell Industries Inc comprise the manufacturing and sales of injection-molded plastic parts and components and electronic products assembling. The manufacturing activities are subcontracted to operating in the Macao Special Administrative Region (Macao) of the PRC. It produce a wide variety of plastic parts and components that are used in the manufacture of consumer and industrial products, using different plastic injection technologies, such as film injection, integrated injection and insert injection. It has two segments: plastic injection molding and electronic products assembling. It has generates majority of profit from Electronic Segment. It has presence in China, United States, Europe, Hong Kong, United Kingdom, Canada, and Others of which majority of sales is from China.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: